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Background/aim: Middle East respiratory syndrome (MERS) is a zoonotic viral disease transmitted from dromedaries to humans. To
date, more than 1500 cases of MERS have been reported and 80% of all cases have occurred in the Kingdom of Saudi Arabia (KSA).
This cross-sectional study was carried out to figure out the rate of infection among humans and dromedary camels and to explore the
risk factors.
Materials and methods: This study was conducted in Diyala Province, Iraq for the period from August 2017 to October 2018. Human
subjects included 90 participants; 34 (37.8%) were females and 56 (62.2%) were males. Additionally, 90 dromedary camels were also
included, 50 (55.6%) males and 40 (44.4%) females. Serum samples from subjects were collected and tested for the presence of antiMERS-coronavirus (CoV) immunoglobulin g (IgG).
Results: The results revealed that 46 (51.1%) of human subjects were positive for anti-MERS-CoV IgG, (95% confidence interval (CI)
for the prevalence rate 40.9–61.3) with a mean titer of anti-MERS-CoV IgG antibodies (Ab) of 81.2 U/mL. The anti-MERS-CoV IgG
positivity rate was insignificantly higher, but the mean of anti-MERS-CoV IgG titer was significantly higher among females (p = 0.12
and p < 0.004, respectively). Furthermore, the anti-MERS-CoV IgG positivity rate and Ab titer were significantly higher among those
people who visited KSA for Hajj or Umrah (p < 0.001 and p < 0.001, respectively). In camels, 81 (90.0%) were positive for anti-MERSCoV IgG, (95% CI for the prevalence rate 82.5–94.9), with a mean titer of 99.8 U/mL.
Conclusion: The MERS-CoV infection rate was high among both Iraqi humans and dromedary camels. Further confirmatory studies
are needed, and setting up of national precaution program is essential.
Key words: MERS-CoV, anti-MERS-CoV Ab, Hajj-associated viral infection

1. Introduction
The MERS-CoV infection first emerged in the KSA in
2012 and has spread to 27 countries. However, 80% of
all cases have occurred in KSA and the largest outbreak
outside KSA occurred in South Korea in 2015 [1,2].
Dromedary camels were the only animal species for which
there was convincing evidence that it was a host species
for MERS-CoV and hence a potential source of human
infection [3,4]. Furthermore, epidemiologic investigations
identified dromedary camels as the likely source of
zoonotic transmission of MERS-CoV to humans [5,6]. Of
note, it was well documented that the seroprevalence of
MERS-CoV antibodies was very high reaching up to 100%
in dromedary camels in the Arabian Peninsula as well as
many other African and Asian countries [7-10].
The pattern of shedding and propensity for the upper
respiratory tract infections (URTIs) in dromedary camels

may help explain the lack of systemic illness among
naturally infected camels and the means of efficient camelto-camel and camel-to-human transmission [6,11]. MERSCoV is mainly acquired in dromedaries when they are less
than 1 year of age, and the proportion of seropositivity
increases with age to a seroprevalence of 100% in adult
dromedaries [12,13].
In humans, MERS is mostly known as a lower
respiratory tract disease involving fever, cough, breathing
difficulties and pneumonia that may progress to acute
respiratory distress syndrome, multiorgan failure, and
death in 20% to 40% of cases (the percentage increases
with age); however, MERS-CoV has also been detected
in mild and influenza-like illnesses and in those with no
signs or symptoms [5,14]. The median incubation period
was 5.2 days (1.9 to 14.7), and the serial interval was 7.6
days (2.5 to 23.1) [15]. Most confirmed cases so far were
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part of MERS-CoV clusters in hospital settings, affecting
mainly middle-aged men and patients with a preexisting
chronic morbidities or immunosuppressed status and the
male to female ratio was 1.7:1 [16,17].
Clinically, it has been reported that the predominant
comorbidities included hypertension, diabetes, respiratory,
and renal disease, and the fever was the most common
complaint [15]. Among other reported risk factors were
healthcare workers and higher exposure occupations that
bring people into close contact with camels which might
be the source of infection for patients with confirmed
MERS with no previous exposure to camels [18,19]. A
systematic review and metaanalysis studies investigated
people from different countries who visited the KSA for
Hajj pilgrimage or Umrah had denied any infection by
MERS-CoV in their citizens after their return form KSA
[20-22]. There are ongoing efforts to develop MERS-CoV
vaccines for humans and dromedary camels [23].

significance of difference of different means (quantitative
data) was tested using Student’s t-test for difference
between two independent means or ANOVA test for
difference among more than two independent means.
The significance of difference of different percentages
(qualitative data) was tested using Pearson’s chi-squared
test (χ2-test) with application of Yate’s correction or Fisher’s
exact test whenever applicable. Statistical significance was
considered whenever the p-value was equal to or less than
0.05.
3. Results
The Shapiro–Wilk test was conducted to check if the normal
distribution model fits the observations, and since the
sample size is greater than 50, the normal approximation
was used to calculate the p-value (a significance level (α)
of 0.05 was used). For the human subjects, the Shapiro–
Wilk test did not show a significant departure from the
normality [W(90) = 0.9731, p = 0.05899]. Similarly, the
Shapiro–Wilk test did not show a significant departure
from the normality for camels [W(90) = 0.9726, p =
0.0539].
Results revealed that 46 (51.1%) of humans were
positive for anti-MERS-CoV IgG, with 95% confidence
interval for the prevalence rate 40.9–61.3. Additionally,
the interquartile range of anti-MERS-CoV IgG titer was
5–19.7 U/mL with a mean of 81.2 U/mL.
Looking at Table 1, it is clear that there was
insignificantly higher MERS-CoV IgG positivity rate and
anti-MERS-CoV IgG Ab titer among humans 40–49 years
old compared to other age groups (p = 0.08 and p = 0.11,
respectively).
The anti-MERS-CoV IgG positivity rate was
insignificantly higher among female humans compared
to males (61.8% vs 44.6%, p = 0.12), However, the mean,
median and interquartile range of anti-MERS-CoV IgG
titer were significantly higher among females (p < 0.004)
as shown in Table 2.

2. Materials and methods
This study was conducted in Diyala Province, Iraq for
the period from mid-August 2017 to the end of October
2018. Human subjects included 90 participants who
were subdivided into 3 groups; 40 individuals had close
contact with camels, 20 were normal healthy individuals,
and 30 were individuals who had visited KSA for Hajj or
Umrah. Of the participants, 34 (37.8%) were females and
56 (62.2%) were males. The age range was 22–59 years.
Additionally, 90 dromedary camels were also included; 50
(55.6%) males and 40 (44.4%) females. The age range was
1–15 years. Serum samples from subjects were collected
and tested for the presence of anti-MERS-CoV IgG using
the recombivirus human anti-MERS-CoV spike protein
S1 domain (MERS-S1) IgG ELISA kit (Alpha Diagnostic
International, USA).
Statistical analysis was done using SPSS (IBM-SPSS),
Version 23. Data were presented in simple measures of
frequency, percentage, mean, median, and range. The

Table 1. The anti-MERS-CoV IgG positivity rate and titer by age groups in humans.

Age groups (No.)

IgG-positive
humans (%)

Serum anti-MERS-CoV IgG titer (U/mL)
95% CI for
prevalence rate Range
Median Interquartile range

Mean rank

< 40 (30)

12 (40)

24–57.8

1.7–83

2.7

1.8–3.9

38.2

40–49 (26)

18 (69.2)

50.2–84.2

1.6–94.1

4.5

2.2–72.6

52.6

50–59 (34)

16 (47.1)

31.1–63.5

1.7–94.3

2.6

2–75.6

46.5

p-value

0.08

0.11
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The results in Table 3 showed that the anti-MERS-CoV
IgG positivity rate among people who visited KSA for Hajj
or Umrah (93.3%) was significantly higher compared to
other groups (p < 0.001).
Likewise, the anti-MERS-CoV IgG Ab titer was
significantly higher among people who visited KSA for
Hajj or Umrah compared to other groups (p < 0.001).
The results also showed that human participants
without symptoms had significantly higher anti-MERSCoV Ab titer compared to those with one or more
symptoms (p = 0.003). The flu-like syndrome was found
to be the only symptom significantly associated with
high anti-MERS-CoV Ab titer (p = 0.001), while other
symptoms including, dry cough, productive cough, sore
throat were insignificantly associated with anti-MERSCoV Ab titer, as demonstrated in Table 4.

In the camels, results revealed that 81 (90.0 %) of
camels were positive for anti-MERS-CoV IgG, with 95%
confidence interval for the prevalence rate 82.5–94.9.
Additionally, the interquartile range of anti-MERS-CoV
IgG titer was 1.6–94.3 with a mean of 99.8 U/mL.
In Table 5, it is clearly obvious that the anti-MERSCoV IgG positivity rate and anti-MERS-CoV IgG titer
were insignificantly higher among camels 10–15 years
old compared to other age groups (p = 0.88 and p = 0.79,
respectively).
The anti-MERS-CoV IgG positivity rate was equally
distributed in female and male camels (90.0%, p = 1), but
the mean, median, and interquartile range of anti-MERSCoV IgG titer was insignificantly higher among males
compared to females (p = 0.57) as shown in Table 6.

Table 2. The anti-MERS-CoV IgG positivity rate and titer by sex in humans.

Sex (No.)

IgG-positive
humans (%)

95% CI for
prevalence rate

Serum anti-MERS-CoV IgG titer (U/mL)
Range

Median

Interquartile range

Mean rank

Female (34)

21 (61.8)

45–76.6

1.7–94.1

21.6

2.4–73.8

55.6

Male (56)

25 (44.6)

32.2–57.7

1.6–94.3

2.4

1.8–4.45

39.4

p–value

0.12

< 0.004

Table 3. Anti-MERS-CoV IgG positivity rate according to human participant groups.
Participant groups

Total No.

Serum IgG-positive humans (%)

95% CI for prevalence rate

Camels close contacts

40

11 (27.5)

15.6–42.5

Normal healthy individuals

20

7 (35)

17.2–56.8

Hajj or Umrah pilgrims

30

28 (93.3)

80.3–98.6

p-value

< 0.001

Table 4. Anti-MERS-CoV IgG titer (U/mL) by clinical symptoms in humans.
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Any symptoms

Total
no.

Serum IgG titer (U/mL)
Range

Median

Interquartile range

Mean rank

Negative

37

1.6–94.1

5.0

2.5–75.6

55.2

Positive

53

1.7–94.3

2.3

1.8–3.9

38.8

Flu-like symptoms

Total
No.

Serum IgG titer (U/mL)
Range

Median

Interquartile range

Mean rank

Negative

68

1.6–94.3

2.3

2.3

37.9

Positive

22

2–94.1

69.2

69.2

69

p-value
p = 0.003

p-value
p = 0.001

HASAN et al. / Turk J Med Sci
Table 5. The anti-MERS-CoV IgG positivity rate and titer by age groups in camels.
Age groups (no.)

IgG positive
camels (%)

95% CI for
prevalence rate

Serum anti-MERS-CoV IgG titer (U/mL)
Range

Median

Interquartile range Mean rank

< 5 (18)

16 (88.9)

68.9–97.6

0.7–49.3

11.2

4.5–17.6

41.9

5–9 (35)

31 (88.6)

75.1–96

0.8–37.5

12.2

5–20.7

45.8

10–15 (37)

34 (91.9)

79.9–97.7

0.6–55.1

13.1

5.6–20.2

47

p-value

0.88

0.79

Table 6. The anti-MERS-CoV IgG positivity rate and titer by sex in camels.
Sex (No.)

IgG-positive
camels (%)

95% CI for
prevalence rate

Serum anti-MERS-CoV IgG titer (U/mL)
Range

Median

Interquartile range

Mean rank

Female (40)

36 (90%)

78–96.5

0.8–55.1

11.7

4.5–19.2

43.8

Male (50)

45 (90%)

79.5–96.1

0.6–49.3

13.6

5.1–20.7

46.9

p-value

1

0.57

4. Discussion
To the best of our knowledge, this cross-sectional study
is the first one in Iraq on MERS-CoV infection. Probably
the only single limitation is the small sample size of both
subjects included, merely because this study was personally
funded and the laboratory diagnostic kits were costly.
Certainly, the most fascinating result of this study is
the high infection rate of MERS-CoV among Iraqi camels,
which also harbor high anti-MERS-CoV IgG titer that
certainly reflects the presence of high viral load. Similar
results had been obtained from camels in the Middle East,
particularly Arabian Peninsula, Africa, and Asia [4,6,9,17].
Additionally, 84.5% of serologically tested camels from
Egypt and 91.4% camels from Sudan had MERS-CoV
neutralizing antibodies [8]. The importance of these
results is streaming from the regional and global scientific
consent that dromedary camels are the only animal species
for which there were convincing evidences that it is a host
species for MERS-CoV and hence a potential source of
human infections [24,25].
Geographically, it is well known that Iraq has a long
common land borders with KSA, the country where the
MERS-CoV was first recognized in 2012, and the single
country which reported more than 80% of the MERS-CoV
cases worldwide [26]. These borders are mostly deserts in
which the camels form the main vehicle across the borders
for trading. Earlier epidemiological surveys had affirmed
that the MERS-CoV was endemic in Saudi’s camels and
that Saudi Arabian dromedary camels show significantly
higher MERS-CoV carrier rates than dromedary camels
imported from Africa [18]. This high prevalence of
infection with MERS-CoV actually was responsible for

large human MERS-CoV outbreaks in KSA [1,18,27]. The
presence of high anti-MERS-CoV Ab titer among Iraqi
camels probably reflects the presence of high viral load and
consequently high shedding of the virus with respiratory
secretions and thus high infectivity of these camels.
Several studies had documented that camels with high
viral load were able to shed the MERS-CoV particularly
with respiratory secretions for long duration [7,11,24].
Therefore, it is crucial to conduct further studies on Iraqi
camels for molecular detection of MERS-coronaviral
RNA, and to investigate the infectiousness of these camels.
The results also revealed that there is insignificantly
higher positivity rate among camels 10–15 years old plus
insignificantly higher anti-MERS-CoV IgG Ab titer among
the same age group. This finding was controversial among
previous studies [7,16]. However, generally it has been
found that MERS-CoV seroprevalence increased with age
of camels [12]. Accordingly, the results of this study seem
reasonable and acceptable since older camels are usually
used for trading across the Iraqi-KSA borders, and hence
have more chance to catch the MERS-CoV infection from
carrier camels [3], or through importation of camels from
endemic areas, and in this regard, it was found that Saudi
Arabian dromedary camels had significantly higher MERSCoV carrier rates than dromedary camels elsewhere [2].
Additionally, younger camels may still have protective
levels of maternal anti-MERS-CoV Ab. Therefore, further
studies are needed on Iraqi dromedary camels to address
these queries.
The present results found that 46 (51.1%) of Iraqi
population were seropositive for anti-MERS-CoV IgG,
with a mean of 81.2 U/mL of anti-MERS-CoV IgG titer.
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That is a really high infection rate. Unfortunately, similar
studies were scarce in the literature. However, in KSA it
has been found that the anti-MERS-CoV antibodies were
confirmed in 0.15% of 10,009 people tested in six of the 13
provinces [1,28]. Actually, that necessitates urgent local or
country-wide surveillance studies to affirm these data and
for setting up effective national control precautions.
Moreover, a significantly higher infection rate was
recorded among those people who had previous travel to
KSA for Hajj or Umrah (93.3%), plus a significantly higher
anti-MERS-CoV IgG Ab titer (mean serum IgG titer was
72 U/mL). Upon reviewing the literature, several countries
had denied any infection by MERS-CoV in their citizens
after their return form KSA, while other countries affirmed
these infections [16,20-22]. More comprehensively, it was
found that severe acute respiratory syndrome (SARS)
coronavirus and MERS coronavirus were never isolated
in Hajj pilgrims, and that the most commonly isolated
viruses from symptomatic patients during the Hajj by PCR
were rhinovirus (5.9%–48.8%), followed by influenza virus
(4.5-13.9%) and non-MERS coronaviruses (2.7%–13.2%)
[14]. Probably, this is the most acceptable explanation
for the 35% MERS-CoV infection rate among normal
healthy population in our study. It is important to know
that person-to-person transmission of MERS-CoV is still
mostly limited to health care settings [16,25]. Therefore,
further studies are needed to verify the present results.
The results also revealed that 27.5% of camel’s contacts
(camel’s owners and slaughter house workers) were
positive for anti-MERS-CoV IgG with a mean IgG titer of
30.2 U/mL. These results are not unusual as many previous
studies had ascertained the central role of camels for
transmission of MERS-CoV to human contacts [3,5,10].
An epidemiological study had reported that MERS-CoV
human cases without documented contact with another
human MERS-CoV case make up 61% (517/853) of all
reported cases, and dromedary camels are the only animals
that can transmit infection to human [24]. The long
duration of viral shedding from infected camels provided
further evidence of the zoonotic potential of MERS-CoV
infection and strongly suggested that camels may have a
role in the transmission of the virus to humans [6]. The
present study also found that the anti-MERS-CoV IgG
positivity rate and the anti-MERS-CoV IgG Ab titer were

insignificantly higher among those who are 4–49 years
old. These results are in agreement with those reported by
other epidemiological studies in KSA which affirm that
the majority of the affected patients were aged ≥40 years
[2,15,27].
Regarding the sex, the anti-MERS-CoV IgG positivity
rate and the anti-MERS-CoV IgG titer was insignificantly
higher among females. Although the results in this respect
were controversial, males were predominant [2,15,26].
Clinically, among all symptoms investigated including,
dry cough, productive cough, sore throat, and shortness of
breath, only flu-like syndrome was significantly associated
with high anti-MERS-CoV Ab titer. Additionally, the
anti-MERS-CoV IgG titers were significantly higher
among asymptomatic participants compared to those
with one or more symptoms, since the current infection
in symptomatic participants had yet to yield a high Ab
titer, whereas asymptomatic participants, most probably,
had contracted MERS-CoV previously and developed
a high Ab titer ever since. Studies in this regard had
yielded variable results. Among patients with confirmed
MERS-CoV infection in KSA, 81% were symptomatic at
presentation, with fever being the most common complaint
[15]. Similar results had been reported by other studies
[2,22,27]. It is important to mention that asymptomatic
or mild MERS-CoV infection was recognized in UAE and
during the Korean outbreak but transmission from these
cases was not reported [5,15,29].
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